Cytosorbents
company
About
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
- 101 - 250
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $719K
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1997
- Number Of Employee
- 101 - 250
- Operating Status
- Active
CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$719K
Cytosorbents has raised a total of
$719K
in funding over 2 rounds. Their latest funding was raised on
Aug 14, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 14, 2017 | Grant | $719K | 1 |
U.S. Army Medical Research & Development Command
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Cytosorbents is funded by 1 investors.
U.S. Army Medical Research & Development Command
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
U.S. Army Medical Research & Development Command
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
